Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.

Lubsen, Jacobus; Wagener, Gilbert; Kirwan, Bridget-Anne; de Brouwer, Sophie; Poole-Wilson, Philip A

Lubsen, Jacobus; Wagener, Gilbert; Kirwan, Bridget-Anne; de Brouwer, Sophie; Poole-Wilson, Philip A.

Affiliation

Lubsen J; SOCAR Research SA, Nyon, Switzerland. jlubsen@compuserve.com

J Hypertens ; 23(3): 641-8, 2005 Mar.

Article in En | MEDLINE | ID: mdl-15716708

Subject(s)

Angina Pectoris/drug therapy; Angina Pectoris/mortality; Calcium Channel Blockers/administration & dosage; Hypertension/drug therapy; Hypertension/mortality; Nifedipine/administration & dosage; Adrenergic beta-Antagonists/administration & dosage; Aged; Blood Pressure/drug effects; Coronary Artery Disease/drug therapy; Coronary Artery Disease/mortality; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Morbidity; Risk Factors; Stroke/drug therapy; Stroke/mortality

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Calcium Channel Blockers / Nifedipine / Hypertension / Angina Pectoris Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Hypertens Year: 2005 Type: Article Affiliation country: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links